1) AGE inhibitor
糖基化终产物抑制剂
2) AGEs inhibitor
糖基化终末产物抑制剂
3) inhibitors of advanced glycation end products
糖基化终产物形成抑制剂
1.
The inhibitors of advanced glycation end products(AGEs) for treatment of diabetic complications were introduced, their mechanisms of action, prospects of application and future development were reviewed.
介绍几种治疗糖尿病慢性并发症的糖基化终产物形成抑制剂 ,简述了它们的作用机制、应用和开发前
4) breakers of advanced glycation end products
糖基化终产物断裂剂
5) advanced glycation end products
糖基化终产物
1.
The role of advanced glycation end products in periodontal diseases;
糖基化终产物在牙周病中的作用
2.
Effects of tetramethylpyrazine on expression of vascular endothelium growth factor induced by advanced glycation end products on retinal pigment epithelium;
川芎嗪对糖基化终产物诱导人视网膜色素上皮细胞表达血管内皮生长因子的影响
3.
Effects of advanced glycation end products on the cultured rabbit retinal Müller cells;
糖基化终产物对体外培养兔视网膜Müller细胞的影响
6) advanced glycation end products
糖基化终末产物
1.
The relevance of advanced glycation end products to eye disease;
糖基化终末产物在眼部疾病中的作用
2.
Effects of advanced glycation end products on the expression of matrix metalloproteinase 9 in cultured human RPE cells;
糖基化终末产物对体外培养人视网膜色素上皮细胞表达MMP-9的影响
3.
Protective effect of cariporide on the endothelial impairment caused by advanced glycation end products in rats;
Cariporide对糖基化终末产物所致血管内皮损伤的保护作用
补充资料：醛糖还原酶抑制剂
分子式：
CAS号：
性质：抑制醛糖还原酶（EC1,1,1,21）活性的化合物。醛糖还原酶的哺乳动物体内催化葡萄糖向山梨醇的转化，这是糖尿病后遗症如白内障和神经疾病的主要起因。醛糖还原酶抑制剂可有效抑制糖尿病病人许多器官中山梨醇含量的异常升高，因此这类抑制剂，如Thiazocin A和B等可作为糖尿病后遗症的防治药。
CAS号：
性质：抑制醛糖还原酶（EC1,1,1,21）活性的化合物。醛糖还原酶的哺乳动物体内催化葡萄糖向山梨醇的转化，这是糖尿病后遗症如白内障和神经疾病的主要起因。醛糖还原酶抑制剂可有效抑制糖尿病病人许多器官中山梨醇含量的异常升高，因此这类抑制剂，如Thiazocin A和B等可作为糖尿病后遗症的防治药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条